TNFRSF10D expression is also associated with prostate cancer and with the direct p53 effectors and ERK signaling pathways; here, TNFRSF10D was inversely related to prostate cancer biochemical recurrence risk score. The gene discussed is TP53; the disease is prostate carcinoma.